pyrazinamide has been researched along with Hematologic Malignancies in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Slomovich, S | 1 |
| Oh, KT | 1 |
| Diakos, NA | 1 |
| Restaino, SW | 1 |
| Clerkin, KJ | 1 |
| Latif, F | 1 |
| Miyauchi, JT | 1 |
| Lee, A | 1 |
| Sayer, GT | 1 |
| Uriel, N | 1 |
1 other study available for pyrazinamide and Hematologic Malignancies
| Article | Year |
|---|---|
A Rare Case of Disseminated Tuberculosis and Hematological Malignancy in a Heart Transplant Recipient.
Topics: Aged; Antitubercular Agents; Heart Transplantation; Hematologic Neoplasms; Humans; Isoniazid; Male; | 2021 |